These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 27200503

  • 1. Leptin administration in physiological or pharmacological doses does not alter circulating irisin levels in humans.
    Gavrieli A, Panagiotou G, Mantzoros CS.
    Int J Obes (Lond); 2016 Sep; 40(9):1461-3. PubMed ID: 27200503
    [Abstract] [Full Text] [Related]

  • 2. Preadipocyte factor-1 levels are higher in women with hypothalamic amenorrhea and are associated with bone mineral content and bone mineral density through a mechanism independent of leptin.
    Aronis KN, Kilim H, Chamberland JP, Breggia A, Rosen C, Mantzoros CS.
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1634-9. PubMed ID: 21795455
    [Abstract] [Full Text] [Related]

  • 3. Circulating levels of the components of the GH/IGF-1/IGFBPs axis total and intact IGF-binding proteins (IGFBP) 3 and IGFBP 4 and total IGFBP 5, as well as PAPPA, PAPPA2 and Stanniocalcin-2 levels are not altered in response to energy deprivation and/or metreleptin administration in humans.
    Pilitsi E, Peradze N, Perakakis N, Mantzoros CS.
    Metabolism; 2019 Aug; 97():32-39. PubMed ID: 31103608
    [Abstract] [Full Text] [Related]

  • 4. Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women.
    Sienkiewicz E, Magkos F, Aronis KN, Brinkoetter M, Chamberland JP, Chou S, Arampatzi KM, Gao C, Koniaris A, Mantzoros CS.
    Metabolism; 2011 Sep; 60(9):1211-21. PubMed ID: 21741057
    [Abstract] [Full Text] [Related]

  • 5. Leptin treatment reduces body fat but does not affect lean body mass or the myostatin-follistatin-activin axis in lean hypoleptinemic women.
    Brinkoetter M, Magkos F, Vamvini M, Mantzoros CS.
    Am J Physiol Endocrinol Metab; 2011 Jul; 301(1):E99-E104. PubMed ID: 21505147
    [Abstract] [Full Text] [Related]

  • 6. Leptin administered in physiological or pharmacological doses does not regulate circulating angiogenesis factors in humans.
    Aronis KN, Diakopoulos KN, Fiorenza CG, Chamberland JP, Mantzoros CS.
    Diabetologia; 2011 Sep; 54(9):2358-67. PubMed ID: 21660636
    [Abstract] [Full Text] [Related]

  • 7. Omentin-1 levels are reduced by pharmacologic doses of leptin, but remain unaffected by energy deprivation and display no day-night variation.
    Hamnvik OR, Thakkar B, Chamberland J, Aronis K, Schneider B, Mantzoros CS.
    Int J Obes (Lond); 2015 Feb; 39(2):260-264. PubMed ID: 24946907
    [Abstract] [Full Text] [Related]

  • 8. Selective capacity of metreleptin administration to reconstitute CD4+ T-cell number in females with acquired hypoleptinemia.
    Matarese G, La Rocca C, Moon HS, Huh JY, Brinkoetter MT, Chou S, Perna F, Greco D, Kilim HP, Gao C, Arampatzi K, Wang Z, Mantzoros CS.
    Proc Natl Acad Sci U S A; 2013 Feb 26; 110(9):E818-27. PubMed ID: 23382191
    [Abstract] [Full Text] [Related]

  • 9. Circulating Irisin Levels Are Not Regulated by Nutritional Status, Obesity, or Leptin Levels in Rodents.
    Quiñones M, Folgueira C, Sánchez-Rebordelo E, Al-Massadi O.
    Mediators Inflamm; 2015 Feb 26; 2015():620919. PubMed ID: 26568663
    [Abstract] [Full Text] [Related]

  • 10. The effect of leptin replacement on parathyroid hormone, RANKL-osteoprotegerin axis, and Wnt inhibitors in young women with hypothalamic amenorrhea.
    Foo JP, Polyzos SA, Anastasilakis AD, Chou S, Mantzoros CS.
    J Clin Endocrinol Metab; 2014 Nov 26; 99(11):E2252-8. PubMed ID: 25148234
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of subcutaneous recombinant methionyl human leptin administration in healthy subjects in the fed and fasting states: regulation by gender and adiposity.
    Chan JL, Wong SL, Mantzoros CS.
    Clin Pharmacokinet; 2008 Nov 26; 47(11):753-64. PubMed ID: 18840030
    [Abstract] [Full Text] [Related]

  • 12. Irisin and leptin concentrations in relation to obesity, and developing type 2 diabetes: A cross sectional and a prospective case-control study nested in the Normative Aging Study.
    Sahin-Efe A, Upadhyay J, Ko BJ, Dincer F, Park KH, Migdal A, Vokonas P, Mantzoros C.
    Metabolism; 2018 Feb 26; 79():24-32. PubMed ID: 29108900
    [Abstract] [Full Text] [Related]

  • 13. Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones.
    Rosenbaum M, Murphy EM, Heymsfield SB, Matthews DE, Leibel RL.
    J Clin Endocrinol Metab; 2002 May 26; 87(5):2391-4. PubMed ID: 11994393
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin tolerance.
    Moon HS, Matarese G, Brennan AM, Chamberland JP, Liu X, Fiorenza CG, Mylvaganam GH, Abanni L, Carbone F, Williams CJ, De Paoli AM, Schneider BE, Mantzoros CS.
    Diabetes; 2011 Jun 26; 60(6):1647-56. PubMed ID: 21617185
    [Abstract] [Full Text] [Related]

  • 15. Comparison of efficacy and safety of leptin replacement therapy in moderately and severely hypoleptinemic patients with familial partial lipodystrophy of the Dunnigan variety.
    Simha V, Subramanyam L, Szczepaniak L, Quittner C, Adams-Huet B, Snell P, Garg A.
    J Clin Endocrinol Metab; 2012 Mar 26; 97(3):785-92. PubMed ID: 22170723
    [Abstract] [Full Text] [Related]

  • 16. Longitudinal variation of circulating irisin after an energy restriction-induced weight loss and following weight regain in obese men and women.
    Crujeiras AB, Pardo M, Arturo RR, Navas-Carretero S, Zulet MA, Martínez JA, Casanueva FF.
    Am J Hum Biol; 2014 Mar 26; 26(2):198-207. PubMed ID: 24375850
    [Abstract] [Full Text] [Related]

  • 17. Circulating fetuin-A levels are not affected by short and long-term energy deprivation and/or by leptin administration.
    Hwang JJ, Thakkar B, Chamberland JP, Mantzoros CS.
    Metabolism; 2014 Jun 26; 63(6):754-9. PubMed ID: 24703486
    [Abstract] [Full Text] [Related]

  • 18. Fibroblast growth factor 21 levels in young healthy females display day and night variations and are increased in response to short-term energy deprivation through a leptin-independent pathway.
    Foo JP, Aronis KN, Chamberland JP, Paruthi J, Moon HS, Mantzoros CS.
    Diabetes Care; 2013 Apr 26; 36(4):935-42. PubMed ID: 23193213
    [Abstract] [Full Text] [Related]

  • 19. Short-term energy deprivation alters activin a and follistatin but not inhibin B levels of lean healthy women in a leptin-independent manner.
    Moragianni VA, Aronis KN, Chamberland JP, Mantzoros CS.
    J Clin Endocrinol Metab; 2011 Dec 26; 96(12):3750-8. PubMed ID: 21917874
    [Abstract] [Full Text] [Related]

  • 20. Circulating irisin and glucose metabolism in overweight/obese women: effects of α-lipoic acid and eicosapentaenoic acid.
    Huerta AE, Prieto-Hontoria PL, Fernández-Galilea M, Sáinz N, Cuervo M, Martínez JA, Moreno-Aliaga MJ.
    J Physiol Biochem; 2015 Sep 26; 71(3):547-58. PubMed ID: 25820474
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.